Is septal glucose metabolism altered in patients with left bundle branch block and ischemic cardiomyopathy?

Journal of Nuclear Medicine

Volumn 47, Issue 11, 2006, Pages 1763-1768

  Thompson, Kerry ^a   Saab, George ^b   Birnie, David ^a   Chow, Benjamin J W ^a,c   Ukkonen, Heikki ^d   Ananthasubramaniam, Karthik ^a,e   DeKemp, Robert A ^a   Garrard, Linda ^a   Ruddy, Terrence D ^a,c   DaSilva, Jean N ^a   Beanlands, Rob S B ^a,c  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d TURKU PET CENTRE   (Finland)

^e HENRY FORD HOSPITAL   (United States)

Author keywords

Ischemic heart disease; Left bundle branch block; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; RUBIDIUM 82;

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ELECTROCARDIOGRAPHY MONITORING; FEMALE; GLUCOSE METABOLISM; HEART EJECTION FRACTION; HEART LEFT ANTERIOR BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE PERFUSION; HEART VENTRICLE SEPTUM; HEART VENTRICLE WALL; HEART VENTRICULOGRAPHY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL HIBERNATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QRS COMPLEX; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; CARDIOMYOPATHY; ELECTROCARDIOGRAPHY; HEART BUNDLE BRANCH BLOCK; HEART MUSCLE; HEART MUSCLE ISCHEMIA; IMAGE PROCESSING; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PERFUSION;

AGED; BUNDLE-BRANCH BLOCK; CARDIOMYOPATHIES; ELECTROCARDIOGRAPHY; FEMALE; GLUCOSE; HEART SEPTUM; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PERFUSION; POSITRON-EMISSION TOMOGRAPHY;

EID: 33846878359     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. McMurray JJ, Pfeffer MA. Heart failure. Lancet. 2005;365:1877-1889.
2. Baldasseroni S, Opasich C, Gorini M, et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J. 2002;143:398-405.
3. Lindner O, Vogt J, Baller D, et al. Global and regional myocardial oxygen consumption and blood flow in severe cardiomyopathy with left bundle branch block. Eur J Heart Fail. 2005;7:225-230.
4. Nowak B, Sinha AM, Schaefer WM, et al. Cardiac resynchronization therapy homogenizes myocardial glucose metabolism and perfusion in dilated cardiomyopathy and left bundle branch block. J Am Coll Cardiol. 2003;41:1523-1528.
5. St. John Sutton MG, Plappert T, Abraham WT, et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation. 2003;107:1985-1990.
6. Penicka M, Bartunek J, De Bruyne B, et al. Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue Doppler imaging echocardiography. Circulation. 2004;109:978-983.
7. Sundell J, Engblom E, Koistinen J, et al. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure. J Am Coll Cardiol. 2004;43:1027-1033.
8. Knaapen P, van Campen LMC, de Cock CC, et al. Effects of cardiac resynchronization therapy on myocardial perfusion reserve. Circulation. 2004;110:646-651.
9. Neri G, Zanco P, Zanon F, Buchberger R. Effect of biventricular pacing on metabolism and perfusion in patients affected by dilated cardiomyopathy and left bundle branch block: evaluation by positron emission tomography. Europace. 2003;5:111-115.
10. Nowak B, Stellbrink C, Schaefer WM, et al. Comparison of regional myocardial blood flow and perfusion in dilated cardiomyopathy and left bundle branch block: role of wall thickening. J Nucl Med. 2004;45:414-418.
11. Diaz-Infante E, Mont L, Leal J, et al. Predictors of lack of response to resynchronization therapy. Am J Cardiol. 2005;95:1436-1440.
12. Bax JJ, Bleeker GB, Marwick TH, et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol. 2004;44:1834-1840.
13. Birnie DH, Tang A. The problem of non-response to cardiac resynchronization therapy. Curr Opin Cardiol. 2006;21:20-26.
14. Yu CM, Fung WH, Lin H, Zhang Q, Sanderson JE, Lau CP. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol. 2003;91:684-688.
15. Molhoek SG, Bax JJ, Boersma E, et al. QRS duration and shortening to predict clinical response to cardiac resynchronization therapy in patients with end-stage heart failure. Pacing Clin Electrophysiol. 2004;27:308-313.
16. Lecoq G, Leclercq C, Leray E, et al. Clinical and electrocardiographic predictors of a positive response to cardiac resynchronization therapy in advanced heart failure. Eur Heart J. 2005;26:1094-1100.
17. Davis DR, Krahn AD, Tang A, et al. Long-term outcome of cardiac resynchronization therapy in patients with severe congestive heart failure. Can J Cardiol. 2005;21:413-417.
18. St. John Sutton MG, Plappert T, Hilpisch KE, Abraham WT, Hayes DL, Chinchoy E. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Circulation. 2006;113:266-272.
19. Ukkonen H, Beanlands RSB, Burwash IG, et al. Effect of cardiac resynchronization on myocardial efficiency and regional oxidative metabolism. Circulation. 2003;107:28-31.
20. Zanco P, Desideri A, Mobilia G, et al. Effects of left bundle branch block on myocardial FDG PET in patients without significant coronary artery stenoses. J Nucl Med. 2000;41:973-977.
21. Willems JL, Robles de Medina EO, Bernard R, et al. Criteria for intraventricular conduction disturbances and pre-excitation: World Health Organizational/International Society and Federation for Cardiology Task Force Ad Hoc. J Am Coll Cardiol. 1985;5:1261-1275.
22. 82Rb PET. J Nucl Med. 2000;41:1426-1435.
23. Parkash R, deKemp RA, Ruddy TD, et al. Potential utility of rubidium 82 PET quantification in patients with 3-vessel coronary artery disease. J Nucl Cardiol. 2004;11:440-449.
24. Beanlands RSB, Ruddy TD, deKemp RA, et al. Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function. J Am Coll Cardiol. 2002;40:1735-1743.
25. Bacharach S, Bax JJ, Case J, et al. American Society of Nuclear Cardiology practice guidelines: PET myocardial glucose metabolism and perfusion imaging. J Nucl Cardiol. 2003;10:543-556.
26. 18F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction. J Nucl Med. 2001;42:1730-1736.
27. Haas F, Augustin N, Holper K, et al. Time course and extent of improvement of dysfunctioning myocardium in patients with coronary artery disease and severely depressed left ventricular function after revascularization: correlation with positron emission tomographic findings. J Am Coll Cardiol. 2000;36:1927-1934.
28. Zareba W, Moss A, Jackson Hall W, et al. Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction. J Cardiovasc Electrophysiol. 2005;16:1265-1270.
29. Altehoefer C, vom Dahl J, Buell U. Septal glucose metabolism in patients with coronary artery disease and left bundle-branch block. Coron Artery Dis. 1993;4:569-572.
30. Zanco P, Chierichetti F, Fini A, Cargnel S, Ferlin G. Myocardial perfusion, glucose utilization and oxidative metabolism in a patient with left bundle branch block, prior myocardial infarction and diabetes. J Nucl Med. 1998;39:261-263.
31. Altehoefer C, vom Dahl J, Bares R, Stocklin GL, Bull U. Metabolic mismatch of septal beta-oxidation and glucose utilization in left bundle branch block assessed with PET. J Nucl Med. 1995;36:2056-2059.
32. Cleland JGF, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539-1549.
33. Neri G, Zanco P, Buchberger R. Myocardial perfusion and metabolic changes induced by biventricular pacing in dilated cardiomyopathy and left bundle branch block: description of a case evaluated by positron emission tomography. Ital Heart J. 2001;2:472-474.
34. Bleeker GB, Kaandorp TAM, Lamb HJ, et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation. 2006;113:969-976.
35. Yu CM, Zhang Q, Fung JW-H, et al. A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging. J Am Coll Cardiol. 2005;45:677-684.
36. Reuter S, Garrigue S, Barold SS, et al. Comparison of characteristics in responders versus nonresponders with biventricular pacing for drug-resistant congestive heart failure. Am J Cardiol. 2002;89:346-350.
37. Lindner O, Vogt J, Kammeier A, et al. Effect of cardiac resynchronization therapy on global and regional oxygen consumption and myocardial blood flow in patients with non-ischaemic and ischaemic cardiomyopathy. Eur Heart J. 2005;26:70-76.
38. Gasparini M, Mantica M, Galimberti P, et al. Is the outcome of cardiac resynchronization therapy related to the underlying etiology? Pacing Clin Electrophysiol. 2003;26:175-180.
39. Hummel JP, Lindner JR, Belcik JT, et al. Extent of myocardial viability predicts response to biventricular pacing in ischemic cardiomyopathy. Heart Rhythm. 2005;2:1211-1217.